Poor survival for osteosarcoma of the pelvis: A report from the children's oncology group

Clinical Orthopaedics and Related Research

Volumn 470, Issue 7, 2012, Pages 2007-2013

  Isakoff, Michael S ^a   Barkauskas, Donald A ^b   Ebb, David ^c   Morris, Carol ^d   Letson, G Douglas ^e  

^a Division of Pediatric Infectious Diseases   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; MURAMYL TRIPEPTIDE; RAZOXANE; TOPOTECAN; TRASTUZUMAB;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; DRUG INTERMITTENT THERAPY; EVENT FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; METASTASIS; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIC OSTEOSARCOMA; PELVIS CANCER; PELVIS SURGERY; PRIMARY TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME;

EID: 84864290009     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-012-2284-9     Document Type: Article

References (20)

1. DeLaney TF, Park L, Goldberg SI, Hug EB, Liebsch NJ, Munzenrider JE, Suit HD. Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys. 2005;61:492-498. (Pubitemid 40164446)
2. Donati D, Giacomini S, Gozzi E, Ferrari S, Sangiorgi L, Tienghi A, DeGroot H, Bertoni F, Bacchini P, Bacci G, Mercuri M. Osteosarcoma of the pelvis. Eur J Surg Oncol. 2004;30:332-340. (Pubitemid 38425654)
3. Ferguson WS, Harris MB, Goorin AM, Gebhardt MC, Link MP, Shochat SJ, Siegal GP, Devidas M, Grier HE. Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial. J Pediatr Hematol Oncol. 2001;23:340-348. (Pubitemid 32845659)
4. Fuchs B, Hoekzema N, Larson DR, Inwards CY, Sim FH. Osteosarcoma of the pelvis: outcome analysis of surgical treatment. Clin Orthop Relat Res. 2009;467:510-518.
5. Goorin AM, Schwartzentruber DJ, Devidas M, Gebhardt MC, Ayala AG, Harris MB, Helman LJ, Grier HE, Link MP; Pediatric Oncology Group. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol. 2003;21:1574-1580. (Pubitemid 46594112)
6. Grimer RJ, Carter SR, Tillman RM, Spooner D, Mangham DC, Kabukcuoglu Y. Osteosarcoma of the pelvis. J Bone Joint Surg Br. 1999;81:796-802. (Pubitemid 29438353)
7. Ham SJ, Kroon HM, Koops HS, Hoekstra HJ. Osteosarcoma of the pelvis: oncological results of 40 patients registered by The Netherlands Committee on Bone Tumours. Eur J Surg Oncol. 2000;26:53-60. (Pubitemid 30102824)
8. Jaffe N, Carrasco H, Raymond K, Ayala A, Eftekhari F. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? Cancer. 2002;95: 2202-2210. (Pubitemid 35253383)
9. Kalbfleisch J, Prentice R. The Statistical Analysis of Failure Time Data. 2nd ed. New York, NY: John Wiley and Sons; 2002.
10. Kawai A, Huvos AG, Meyers PA, Healey JH. Osteosarcoma of the pelvis: oncologic results of 40 patients. Clin Orthop Relat Res. 1998;348:196-207. (Pubitemid 28160824)
11. Link MP, Goorin AM, Horowitz M, Meyer WH, Belasco J, Baker A, Ayala A, Shuster J. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity: updated results of the Multi- Institutional Osteosarcoma Study. Clin Orthop Relat Res. 1991; 270:8-14.
12. Mahajan A, Woo SY, Kornguth DG, Hughes D, Huh W, Chang EL, Herzog CE, Pelloski CE, Anderson P. Multimodality treatment of osteosarcoma: radiation in a high-risk cohort. Pediatr Blood Cancer. 2008;50:976-982. (Pubitemid 351500174)
13. Matsuo T, Sugita T, Sato K, Hotta T, Tsuchiya H, Shimose S, Kubo T, Ochi M. Clinical outcomes of 54 pelvic osteosarcomas registered by Japanese musculoskeletal oncology group. Oncology. 2005;68:375-381. (Pubitemid 41160967)
14. Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol. 2005;23: 2004-2011. (Pubitemid 46211380)
15. Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival. A report from the Children's Oncology Group. J Clin Oncol. 2008;26:633-638. (Pubitemid 351264359)
16. Ozaki T, Flege S, Kevric M, Lindner N, Maas R, Delling G, Schwarz R, von Hochstetter AR, Salzer-Kuntschik M, Berdel WE, Jurgens H, Exner GU, Reichardt P, Mayer-Steinacker R, Ewerbeck V, Kotz R, Winkelmann W, Bielack SS. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol. 2003;21:334-341. (Pubitemid 46613482)
17. Renard AJ, Veth RP, Schreuder HW, Pruszczynski M, Bokkerink JP, van Hoesel QG, van Der Staak FJ. Osteosarcoma: oncologic and functional results. A single institutional report covering 22 years. J Surg Oncol. 1999;72:124-129.
18. Ries L, Eisner M, Kosary C, Hankey B, Miller B, Clegg L, Mariotto A, Feuer E, Edwards B. SEER Cancer Statistics Review, 1975-2001, National Cancer Institute. Bethesda, MD; 2004. Available at: http://seer.cancer.gov/csr/1975- 2001/. Accessed December 21, 2011.
19. Saab R, Rao BN, Rodriguez-Galindo C, Billups CA, Fortenberry TN, Daw NC. Osteosarcoma of the pelvis in children and young adults: the St. Jude Children's Research Hospital experience. Cancer. 2005;103:1468-1474. (Pubitemid 40410744)
20. Seibel N, Krailo M, Chen Z, Healey J, Breitfeld P, Drachtman R, Greffe B, Nachman J, Nadel H, Sato J, Meyers P, Reaman G. Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: Children's Cancer Group (CCG) 7943. Cancer. 2007;109: 1646-1653. (Pubitemid 46595701)